GE Healthcare announces FDA 510(k) clearance of SenoBright CESM for breast cancer diagnosis

GE Healthcare announces FDA 510(k) clearance of SenoBright CESM for breast cancer diagnosis
2.5 5

Add a new comment

 avatar